BeStock  
Stocks › Cancer Research › BIIB

Biogen BIIB

US equityMarket cap rank #410Cancer Research
$224.65 −$1.24 (-0.55%)
Market open · Oct 1, 1:10 pm ET · After hours $225.88 0.00%
Open$225.50
Prev close$225.88
Day range$224.19 – $228.31
Volume582.1K
Market cap$33.19B
P/E (TTM)39.9
Dividend yield–

Analyst view

ConsensusBuy
Analysts26
Average target$239.95+6.8% vs. price
  • Buy 65%
  • Hold 31%
  • Sell 4%
Low $175.00Now $224.65Avg $239.95High $300.00

Recent rating changes

The last 20 actions on file set price targets from $175.00 to $300.00, averaging $238.78.

DateFirmRatingTarget
25 Sep 2026 Bernstein BUY $236.00
18 Sep 2026 Wells Fargo BUY $250.00
10 Sep 2026 HSBC SELL $175.00
9 Sep 2026 BMO Capital HOLD –
3 Sep 2026 Piper Sandler BUY $245.00
25 Aug 2026 RBC Capital BUY $260.00
13 Aug 2026 Wolfe Research BUY $300.00
3 Aug 2026 Mizuho Securities BUY $241.00
3 Aug 2026 Citi HOLD $215.00
2 Aug 2026 Stifel BUY $242.00
31 Jul 2026 Truist Financial BUY $235.00
31 Jul 2026 Wedbush HOLD $215.00
30 Jul 2026 TD Cowen BUY $225.00
30 Jul 2026 CCORF BUY $248.00
30 Jul 2026 Wells Fargo BUY $250.00
30 Jul 2026 UBS BUY $240.00
30 Jul 2026 Truist Financial BUY –
30 Jul 2026 Wedbush HOLD $215.00
30 Jul 2026 Jefferies BUY $255.00
30 Jul 2026 H.C. Wainwright BUY $251.00

Discussion

No comments yet — be the first to weigh in on BIIB.

Leave a comment

Scroll to Top